Voiceitt for People With Impairments in Speech

Description

The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.

Conditions

Speech Impairment, Speech Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.

Voiceitt for People With Impairments in Speech

Voiceitt for People With Impairments in Speech

Condition
Speech Impairment
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

Center for Assistive Technology, Pittsburgh, Pennsylvania, United States, 15213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 13 or older
  • * moderately severe speech dysarthria due to conditions such as CP, stroke, ALS or Parkinson's Disease, etc.
  • * Ability to understand and follow instructions for using the Voiceitt app.
  • * Severe cognitive impairments that prevent the understanding of the Voiceitt app and required training.
  • * Patients who have additional speech impairments other than dysarthria, such as significant aphasia or verbal apraxia.
  • * Severe physical impairments that prevent interaction with the app.
  • * Non-English speakers.

Ages Eligible for Study

13 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pittsburgh,

Brad E Dicianno, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

2026-06-26